- Global Pharma News & Resources

Global Market for CMO/CDMO is likely to rise at a 5.7% CAGR from 2023 to 2033, reaching US$ 39.4 Billion: FMI Report

The global CMO/CDMO Market is anticipated to expand significantly, registering a CAGR of 5.7% from 2023 to 2033. In 2023, the global CMO/CDMO market is expected to be worth US$ 22.5 billion. By 2033, the market is expected to be worth US$ 39.4 billion.

As more pharmaceutical companies consider outsourcing their operations, demand for services from contract manufacturing and contract development manufacturing organizations is poised to increase. Future Market Insights (FMI) believes that the CMO/CDMO market has enormous potential for growth in the coming years. An increasing need for generic drugs and biologics is expected to propel the market growth.

Act Now: Gain Exclusive Insights into the Rising Market Value of Market for CMO/CDMO – Our Sample Report!

Currently, an increasing number of consumers prefer locally sourced and natural products over big brands. This will necessitate cutting-edge technology as well as other resources.

Key Takeaways:

  • Over the historical period, the worldwide market grew at a CAGR of 5.3%.
  • The Indian market is expected to expand at a CAGR of 5% in the coming decades.
  • In 2022, North America had a share of the global revenue of more than 17.6%.
  • Over the next few decades, the Chinese market is expected to grow at a CAGR of 5%.
  • In 2022, the contract manufacturing segment held 69.28% of the market.

“The growing trend towards private-label companies has created numerous opportunities for CMO/CDMOs. Customer tastes have shifted lately increasing demand for private-label companies, which is anticipated to present opportunities for CMOs shortly. The shift is primarily due to price, accessibility, variety, and consumer feedback,” says an FMI analyst.

Competitive Landscape:

The vendor landscape in the CMO/CDMO market is consolidated. There is a continuing need for research and development, which is still a key strategy among market players. Strategic collaborations are another common strategy used to gain a competitive advantage

  • An authorization and distribution consent revision between Societal CDMO and Lannett Firm for marketing Verapamil PM and Verelan SR products was executed in July 2022. Societal CDMO is a contract creation and manufacturing organization (CDMO) that emphasizes in the invention and production of small molecules. In conjunction with a ten percent spike in the earnings share portion of revenue from Verapamil PM selling, society is going to observe both instantaneous and anticipated price hikes in development.
  • MilliporeSigma, Merck KGaA’s U.S. and Canada Life Science enterprise, doubled its capability for making high-potent active pharmaceutical ingredients (HPAPI) in June 2022 with the establishment of the facility in Verona, close to Madison, WI. The US$ 65 million, 70,000-square-foot complexes will hire 50 individuals in the community.

Unveil New Perspectives Through Our Innovative Methodology!

Key Companies Profiled:

  • Swiss American CDMO
  • Pierre Fabre Group
  • Zymo Cosmetics
  • Fareva, Biofarma Srl C.F
  • Chemineau, C.O.C.
  • Farmaceutici Srl
  • Paragon Nordic Cosmetic Solutions
  • Kolma
  • Lonza
  • Cho Chuang Industrial Co., Ltd.
  • Vive Cosmetics
  • Ori BioNature Sdn Bhd
  • Zoic Cosmetics
  • Samriddhi Life Sciences
  • Natrocare

Key Segments Profiled in the CMO/CDMO Market Report:

By Service:

  • Contract Development
    • Formulation development
    • Pilot studies
  • Contract Manufacturing
    • Bulk preparation & scale up
    • Safety Testing
    • Filling & Packaging
    • Close jars
    • Bottles
    • Tubes
    • Roll-ons
  • Others


  • Hair Products
  • Skin Products
  • Lip Products
  • Eye Products
  • Body Hygiene
  • Oral Hygiene


  • Solid Form & Powder
  • Lotions
  • Creams
  • Others


  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 11-Sep-2023